http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018060508-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e757fd4fedc4fe825bb81b1b466a0947
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-345
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
filingDate 2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fcd941b50ea33d47ec268c37c7aa6ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c0056dd67c4862cf9f1a389f55b6946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78e2b0fb2414a25822e4e92f2dfdae43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f141d24b29c11996c8bdb8de75f7c7a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaa710c9b88f3055c1f20f46b6235f37
publicationDate 2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018060508-A1
titleOfInvention Personalized tolerance prediction of adverse drug events
abstract Embodiments include method, systems and computer program products for predicting adverse drug events on a computational system. Aspects include receiving a personalized data set including a plurality of real-time drug doses for a first drug or drug combination and a plurality of corresponding real-time adverse drug reaction tolerance data for the first drug or drug combination for a patient. Aspects also include receiving known drug data for a candidate drug or drug pair. Aspects also include calculating, based upon the known drug data and the personalized data set, a predicted adverse drug reaction tolerance for the candidate drug or drug pair at a candidate dosage, wherein the predicted adverse drug reaction tolerance is personalized to the patient
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11087864-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021257088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018330808-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111477344-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110458244-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112712904-A
priorityDate 2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003178031-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009171697-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135415867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491723

Total number of triples: 40.